Episode Details

LB Pharmaceuticals Q4 earnings match analysts predictions, with a loss of $0.45 per share. The full-year loss was $3.13 per share. The steady results provide a clear financial picture for investors as the company moves forward in the pharma industry.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/c904b518f8e1039c